Calvin Sandra - Insider Non-Derivative Transactions at Travere Therapeutics, Inc. (TVTX) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Feb 1, 2024, Calvin Sandra's relationship to Travere Therapeutics, Inc. (TVTX) is Officer (SVP, CHIEF ACCOUNTING OFFICER), and currently has 52,017 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other TVTX insiders.

Data Source: SEC.
Calvin Sandra - Insider Non-Derivative Transactions of TVTX Common Stock
Calvin Sandra - Insider Non-Derivative Transactions at TVTX
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Feb 2, 2024 Sell -- (Common Stock) 2820 8.53 52017
Feb 1, 2024 Acquisition -- (Common Stock) 12500 0 53837
Feb 1, 2024 Acquisition -- (Common Stock) 1000 0 54837
Jan 24, 2024 Sell -- (Common Stock) 910 9.07 41337
May 12, 2023 Sell -- (Common Stock) 122 16.12 42247
May 11, 2023 Sell -- (Common Stock) 436 16.59 42369
Feb 3, 2023 Sell -- (Common Stock) 360 22.42 42805
Feb 2, 2023 Sell -- (Common Stock) 1671 21.75 43165
Feb 1, 2023 Acquisition -- (Common Stock) 10000 0 44836
Jan 26, 2023 Sell -- (Common Stock) 192 21.63 34836
Jan 25, 2023 Sell -- (Common Stock) 905 21.9 35028